非增强MRI用于根治性睾丸切除术后1期睾丸癌患者腹盆腔监测
本研究评估非增强MRI在1期睾丸癌根治性睾丸切除术后监测中检测转移性淋巴结的能力,23例连续患者接受腹盆腔非增强MRI监测,3名盲法阅片放射科医生独立评估。17.4%(4/23)患者出现6枚转移性淋巴结,经验丰富阅片者(R3)敏感度、特异度、AUC均为100%,经验较少者(R1/R2)敏感度均为75%,AUC无显著差异(p=0.383)。
要点
- 1期睾丸癌术后监测中,非增强MRI可检测转移性淋巴结,经验丰富阅片者敏感度、特异度均达100%。
- 经验较少阅片者(R1/R2)敏感度均为75%,假阳性率分别为5.2%和10.5%,提示阅片经验影响诊断准确性。
- 阅片者间一致性为中等至高度(K=0.62),AUC无显著差异(p=0.383)。
关键影像表现/征象
- 17.4%(4/23)患者出现6枚转移性淋巴结,参考标准为较基线新出现且短轴>1.0 cm。
- R1和R2均检出75%(3/4)有异常淋巴结的患者,R3检出全部4例。
- 假阳性判读发生率:R1为5.2%(1/19),R2为10.5%(2/19),R3无假阳性。
诊断标准与关键数值
- R1敏感度75%(95%CI 19.4-99.4%)、特异度94.7%(74.0-99.9%)、AUC 0.85(0.59-1.00)。
- R2敏感度75%(19.4-99.4%)、特异度89.5%(66.9-98.7%)、AUC 0.82(0.57-1.00)。
- R3敏感度100%(95%CI 39.8-100.0%)、特异度100%(82.4-100%)、AUC 1.00(1.00-1.00)。
- 阅片者间AUC无显著差异(p=0.383),阅片者间一致性为中等至高度(K=0.62)。
- 诊断信心评分中位数(范围):R1为5(5-5),R2为4(3-5),R3为5(5-5)。
临床应用与阅片要点
- 非增强MRI可用于1期睾丸癌术后监测,但放射科医生经验不足可能导致假阳性或漏诊。
- 阅片时需关注淋巴结短轴>1.0 cm且较基线新出现的异常,经验较少者应谨慎判读。
局限性
- 样本量小导致阅片者间准确性比较受限(原文:Comparison in accuracy between readers is limited due to the small sample size)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the ability of unenhanced magnetic resonance imaging (MRI) to detect metastatic lymphadenopathy in men with stage 1 testicular cancer on surveillance.
MATERIALS AND METHODS: With IRB approval, we identified 23 consecutive men with stage 1 testicular cancer (diagnosed after orchiectomy) undergoing surveillance with unenhanced MRI of the abdomen and pelvis. Three blinded radiologists (2 inexperienced R1/R2 and 1 experienced R3) independently assessed MRI for: presence, location and size of abnormal lymph nodes and degree of confidence (5-point Likert scale) in diagnosis. Diagnostic accuracy was tabulated and compared between groups using ROC. Inter-observer agreement was assessed using Cohen's kappa statistic.
RESULTS: 17.4% (4/23) men developed 6 metastatic lymph nodes (reference standard: interval development from baseline, size > 1.0 cm short axis). R1 and R2 detected 75% (3/4) patients with abnormal lymph nodes, compared to R3 who detected all four cases. False positive interpretations occurred in: 5.2% (1/19) R1, 10.5% (2/19) R2 and no patients for R3. Sensitivity, specificity and area under the ROC curve (AUC) were: R1: 75% (95% CI 19.4-99.4%), 94.7% (74.0-99.9%) and 0.85 (0.59-1.00), R2: 75% (19.4-99.4%), 89.5% (66.9-98.7%) and 0.82 (0.57-1.00) and, R3: 100% (95% 39.8-100.0%), 100% (82.4-100%) and 1.00 (1.00-1.00) with no difference in AUC between readers (p = 0.383). Comparison in accuracy between readers is limited due to the small sample size. Inter-observer agreement was substantial (K = 0.62). Median (range) degree of confidence scores were rated: R1 5 (5-5), R2 4 (3-5) and, R3 5 (5-5).
CONCLUSION: In this study, unenhanced MRI was adequate for surveillance of stage 1 testicular cancer; however, radiologist inexperience may lead to errors.
引用
- Narine R, Osman H, Wongwaisayawan S, et al. Unenhanced MRI of the abdomen and pelvis for surveillance of patients with stage 1 testicular cancer post-radical orchiectomy. Abdom Radiol (NY). 2020. PMID: 32901295. doi:10.1007/s00261-020-02715-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。